methyldopa has been researched along with penicillamine in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (46.15) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Buchholz, K; Harders, H; Henningsen, B; Maintz, J | 1 |
Krebs, A | 1 |
Kuljak, S; Stern, P | 1 |
Homberg, JC | 1 |
Fortson, WC; Tedesco, FJ | 1 |
Holborow, EJ | 1 |
3 review(s) available for methyldopa and penicillamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Autoimmunity induced by drugs. Immunological characteristics and etiopathogenic hypotheses].
Topics: Animals; Autoimmune Diseases; Cardiac Glycosides; Chemical and Drug Induced Liver Injury; Drug Combinations; Humans; Iproniazid; Lymphocytes; Methimazole; Methyldopa; Penicillamine; Plant Extracts; Pyrazoles; T-Lymphocytes; Ticrynafen | 1984 |
Drug-induced colitis: a review.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Cimetidine; Colitis; Contrast Media; Enema; Enterocolitis, Pseudomembranous; Ergot Alkaloids; Estrogens; Ethanol; Flucytosine; Gold; Humans; Methyldopa; Penicillamine; Progesterone; Soaps; Vasopressins | 1984 |
10 other study(ies) available for methyldopa and penicillamine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Unusual clinical forms of pseudo-LE syndrome: an induced immune-complex disease? (author's transl)].
Topics: Adult; Aged; Antibodies; Bone Marrow Diseases; Female; Humans; Immune Complex Diseases; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Methyldopa; Middle Aged; Mitochondria; Nephritis; Penicillamine; Phenylbutazone; Pyrazoles; Serologic Tests; Vascular Diseases | 1975 |
[Drug-induced Lichen ruber planus].
Topics: Chloroquine; Gold; Humans; Lichen Planus; Methyldopa; Penicillamine; Quinine | 1979 |
Tremor induction in mice and its modification.
Topics: Alcohols; Amides; Animals; Brain Chemistry; Carbon Tetrachloride; Copper; Cysteamine; Female; Hepatolenticular Degeneration; Male; Methyldopa; Mice; Penicillamine; Tremor | 1969 |
Drug effects on autoantibodies and immune complexes.
Topics: Acetylation; Antibodies, Antinuclear; Antigen-Antibody Complex; Arthritis, Rheumatoid; Autoantibodies; Autoimmune Diseases; Binding Sites; Complement C1; Humans; Hydralazine; Immunoglobulin M; Lupus Erythematosus, Systemic; Methyldopa; Penicillamine; Procainamide; Rheumatoid Factor | 1980 |